Quinnipiac’s partnership with Revalia Bio provides student unique, hands-on internship experience
November 19, 2026
November 19, 2026
Gamache said that her internship has been beneficial to her in a variety of ways.
“Working with Revalia Bio has been an incredibly rewarding and eye-opening experience,” she said. “Revalia operates at the intersection of organ perfusion, biotechnology and pharmaceutical research. Their work focuses on using donated human organs and advanced ex vivo perfusion technology to better understand human physiology and how organs respond to different medications and treatments."
Gamache says she is excited about the meaningful impact that she can make with Revalia.
“One aspect of Revalia's work that I find particularly meaningful is its potential to reduce reliance on traditional animal testing by providing researchers with more human-relevant models for studying diseases and evaluating pharmaceutical therapies,” Gamache said. “By maintaining donated organs outside the body through specialized perfusion systems, researchers can study how actual human organs respond to different treatments. This creates exciting opportunities to advance drug development and make pharmaceutical research more representative of human biology."
Revalia Bio operates on high morals, which Gamache says she appreciates.
"I also appreciate the values that guide Revalia, including cultivating deep trust, adapting relentlessly, persevering with uncommon grit and being world-class collaborators," she said. "These values reflect the importance of teamwork, scientific innovation, continuous improvement and the responsibility involved in working with donated human organs.”
Gamache’s internship is practical, interactive work. She explained that her work helps her connect her course material to professional and clinical perfusion work.
“My internship with Revalia Bio gives me hands-on experience in the research and technological applications of organ perfusion, particularly how donated human organs can be maintained and studied outside the body. My primary role is working as an organ perfusionist, where I help manage and monitor the perfusion process to maintain organ function throughout research studies,” she said. “One of the most valuable aspects of this experience has been seeing how the concepts I learn in the classroom connect to real-world research and innovation. It has allowed me to explore different opportunities within the cardiovascular industry while gaining a better understanding of how I can contribute to the field as a future perfusionist.”
Associate Dean of Clinical Education and Partnerships Ken Koiser leads the partnership agreement between Quinnipiac and Revalia Bio. He talked about the partnership’s effect on the School of Health Sciences.
“Partnering with Revalia Bio was a unique opportunity to leverage the diverse expertise in perfusion, biomedical sciences and health related faculty/student research across the School of Health Sciences,” he said. “The entire Revalia leadership team exemplifies the entrepreneurship and lifelong learning we value at Quinnipiac, making facilitation of this partnership both engaging and seamless.”
Clinical Assistant Professor of Biomedical Sciences Tyler Wahl aided in the facilitation of the partnership as well. He added on to Kosior’s strong, positive feelings toward Revalia Bio’s relationship with Quinnipiac, emphasizing a mutual benefit.
“From what I have experienced, this type of industry partnership creates incredible opportunities for all parties involved,” he said. “Cardiovascular perfusion has started getting more involved in organ transplant procurement and transporting organs in devices that provide blood flow between the donor site and recipient hospital. It's an incredible process but a difficult thing to train our students on. The research at Revalia provides our students the experience of doing the procedures in a controlled lab environment, so when they start their career, they have the basic knowledge and technical experience to succeed.”
Kosior and Wahl also gave thanks to Revalia Bio’s chief operating officer and co-founder, Jenna DiRito, who has shown warmth and welcome to Quinnipiac throughout the partnership.
“Jenna is an innovative leader and scientist eager to explore creative partnerships that foster knowledge, valuable learning and support their expanding business,” said Kosior. “Jenna has the unique gifts of being able to see the large-scale potential of Revalia’s mission, while also embracing the impact of partnering with an academic institution like Quinnipiac.”
“Jenna and her team have been wonderful to work with," Wahl added. "From day one, they have welcomed us in, and you can tell that they are genuinely excited to get others involved in their research and take part in the collaborative process they have developed. We couldn't wait to show her all that Quinnipiac has to offer and start brainstorming what was possible through this partnership.”
DiRito explained how valuable Quinnipiac students are to their research.
“Quinnipiac students bring a strong foundation in perfusion science, fresh perspectives and enthusiasm for applying their skills in a unique research environment. Their involvement provides valuable support to our operations team while exposing them to applications of perfusion technology beyond traditional clinical settings,” she said. “Our work requires highly specialized technical expertise, and creating opportunities for students to gain hands-on experience with ex vivo human organ perfusion is mutually beneficial. We're excited to help develop the next generation of perfusionists while building a talented local workforce that can support the continued growth of Revalia and the broader biotechnology industry.”
DiRito emphasized the importance of giving students hands-on, drug development work early in their careers.
“One of the things I'm most excited about is the opportunity to demonstrate how skills traditionally developed for clinical medicine can have a profound impact on the future of drug development. At Revalia, we're using donated human organs that cannot be transplanted to generate human-relevant data that can help researchers develop safer, more effective medicines. Giving students exposure to this work early in their careers helps broaden their understanding of what's possible with their training. We're proud to partner with another Connecticut institution to advance science, support education and create meaningful opportunities for the next generation of innovators.”
Gamache couldn’t agree more, touching on how there are various ways for students to contribute to perfusion.
“I think this partnership demonstrates Quinnipiac's commitment to providing students with experiences that expand their understanding of the profession and introduce them to emerging opportunities within the industry. It also allows students to connect with professionals who are actively working to advance medicine through scientific research and technological innovation," said Gamache. “Opportunities like this are invaluable because they encourage us to think beyond what we learn in the classroom and recognize the many ways we can contribute to the future of perfusion.”
Gamache looks forward to continuing her studies, internship and future contribution to cardiovascular care. She explains why this work is so important to her.
“This experience is particularly meaningful to me on a personal level because I underwent open-heart surgery myself two years ago. Having once been on the patient side of cardiovascular care, pursuing a career in perfusion has given me an entirely different perspective and a deeper appreciation for the people and technology involved in saving lives,” she said. “It is incredibly meaningful to now be working toward a profession that played such an important role in my own life. That experience continues to motivate me throughout my education and reinforces why I chose this career path. I hope one day provide patients and their families with the same level of care, dedication and expertise that made such a difference in my own life.”
Quinnipiac Today is your source for what's happening throughout #BobcatNation. Sign up for our weekly email newsletter to be among the first to know about news, events and members of our Bobcat family who are making a positive difference in our world.
Sign Up Now